Onelife Capital Extends ₹36 Crore Rights Issue to March 16

Introduction

Onelife Capital Advisors Limited has successfully completed its ₹36 crore capital raising initiative through a rights issue. The company's Right Issue Committee extended the closing date from March 6, 2026, to March 16, 2026, to provide eligible shareholders with more time to participate. The allotment of shares was finalized on March 17, 2026, marking the conclusion of the process designed to strengthen the company's financial base.

Rights Issue Structure and Pricing

The rights issue involved the issuance of 24,000,000 fully paid-up equity shares, each with a face value of ₹10. The issue was priced at ₹15 per share, which includes a premium of ₹5 per share. This pricing structure was designed to raise a total of ₹36 crore, assuming full subscription. The entire amount of ₹15 per share was payable upon application, simplifying the investment process for shareholders.

Timeline Extension Explained

The rights issue initially opened on February 23, 2026, with a planned closing date of March 6, 2026. However, in a meeting on March 2, 2026, the Right Issue Committee decided to extend the deadline to ensure wider participation. The new closing date was set for Monday, March 16, 2026. Consequently, the last date for on-market renunciation of rights entitlements was also revised to March 10, 2026. The record date to determine shareholder eligibility remained unchanged at February 16, 2026.

Entitlement and Shareholding Structure

The entitlement ratio for the rights issue was set at 300 rights equity shares for every 167 existing equity shares held by shareholders as of the record date. This structure provided a significant opportunity for existing investors to increase their stake in the company. Following the successful allotment, the company's total number of outstanding equity shares increased from 13,360,000 to 37,360,000, reflecting the substantial expansion of its equity base.

Impact on Company's Financials

The completion of the rights issue has substantially strengthened Onelife Capital's financial position. The company's paid-up equity share capital has increased from ₹13.36 crore to ₹37.36 crore. This infusion of capital is a critical component of the company's strategy for long-term growth and stability, providing the necessary resources to pursue new opportunities and fortify its operations.

Utilization of Proceeds

The net proceeds from the ₹36 crore rights issue are earmarked for specific, strategic purposes. The company has outlined a clear plan for the deployment of these funds to support its subsidiary and for broader corporate objectives.

A significant portion, ₹27 crore, will be invested in the subsidiary, Dealmoney Commodities Private Limited, primarily to fund its margin money requirements. The remaining ₹8.64 crore will be allocated for general corporate purposes, which includes funding operational expenses and other business needs, providing the company with enhanced financial flexibility.

Regulatory Compliance and Allotment

The rights issue was conducted in full compliance with the regulations set forth by the Securities and Exchange Board of India (SEBI). The Letter of Offer was filed with the BSE, NSE, and SEBI. KFin Technologies Limited served as the registrar for the issue, managing the complex allotment process. The Board of Directors confirmed the basis of allotment on March 17, 2026. The new shares are expected to be credited to the demat accounts of eligible shareholders, with listing on the BSE and NSE to follow in due course.

Conclusion

The successful completion of the ₹36 crore rights issue, aided by a strategic extension of the timeline, marks a key milestone for Onelife Capital Advisors. The capital raised will enhance the financial health of its subsidiary and support the company's overall growth strategy. This move demonstrates a well-planned approach to strengthening its balance sheet and funding future operations, positioning the company for sustained performance.